Market Research Report
Middle East and Africa Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type ; Delivery Mode ; Application
|Middle East and Africa Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type ; Delivery Mode ; Application|
Published: July 6, 2021
The Insight Partners
Content info: 119 Pages
Delivery time: 1-2 business days
The Artificial tears market in Middle East and Africa is expected to grow from US$ 53.4 million in 2021 to US$ 72.1 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. The world is witnessing a considerable rise in lifestyle-induced diseases. Eye diseases hold a substantial share in lifestyle-induced diseases due to increased utilization of smartphones, laptops, and computers. The modern lifestyle which includes more usage of the tablet, mobile, and computer screens are responsible for triggering the eye-related problems. Eye health is significantly compromised in this technological era. Long working hours in front of the computers eventually start to affect the health of eyes. Further, the extreme exposure to blue rays emitting from smartphones, tablets, iPads, and laptops causes serious damage to the eyes. Furthermore, according to the same study, an estimated 73% of the population under age 30 has observed these symptoms that are related to the change in lifestyle. Such change in lifestyle would eventually damage the eye health, generating a greater demand for artificial tear drops during the forecast period.
The market for Artificial tears market is segmented into type, delivery mode, and application. Based on type, the artificial tears market is segmented into glycerin derived tears, cellulose derived tears, oil-based emulsion tears, polythylene glycol-based tears, sodium hyaluronate based artificial tears, and propylene glycol-based tears. In 2020, glycerin derived tears segment accounted for the largest share of the market owing to their easy availability and ability to keep eyes moist for long. Glycerin is a humectant, as well as a demulcent and lubricant. Glycerin also has the benefit of promoting epithelial cell growth and reducing the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation.
The COVID-19 pandemic has become the most significant challenge in the region. This challenge would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq, Sudan, Israel, and Yemen, because it will result in reduced imports due to global trade disruptions, which will exacerbate shortages of medical supplies and other goods, resulting in significant price rises. However, the artificial tears market in this pandemic is on rising as increasing incidence of dry eye syndrome (DES). This syndrome is basically triggered by the forces such as prolonged exposure to digital displays due to work from home polices, online meetings, online schooling, and entertainment in the lockdown situation.
The overall Middle East and Africa Artificial tears market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the Middle East and Africa Artificial tears market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Middle East and Africa Artificial tears market. Johnson and Johnson Services, Inc., Alcon Inc., OASIS Medical, AbbVie Inc., Bayer AG, Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., and Bausch Health Companies Inc. are among a few players operating in the Middle East and Africa Artificial tears market.